Delivery Order SPE2DB20D3103-SPE2DB25FP5V7
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Erythromycin 0.5% eye ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,180.03, represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,588.31 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This is a firm fixed-price delivery order with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,110.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% eye ointment on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $5,213.92 to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.16 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment (UDGM) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,507.60 and has an ultimate completion date of September 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents no set-aside designation. This...
- The Defense Logistics Agency awarded a $4,251.74 delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, reflecting competitive award procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $3,960.32 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's Corporate Office...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This non-set-aside, competitively awarded contract carries a ceiling value of $2,139.11 and employs firm fixed-price pricing. The delivery order was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,945.13 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed price contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5V7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment. This firm fixed price delivery order, valued at $2,475.20, represents a non-set-aside competitive award and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to the company's distribution center in Conshohocken, Pennsylvania, with completion scheduled for July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's substantial prime IDC with DLA functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a diverse range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for Erythromycin represents one of numerous competitively awarded transactions under this framework contract, demonstrating AmerisourceBergen's capability to fulfill varied federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/21/25 |